Frequently Asked Questions
The global Anastrozole tablets market is expected to grow at a CAGR of 2.80% in the forecast period from 2021 to 2028.
North America dominates the anastrozole tablets market due to the presence of major key players, upsurge in the product launches, high healthcare expenditure and well-developed healthcare sector in this region.
The major players operating in the anastrozole tablets market report are AstraZeneca, Teva Pharmaceutical Industries Ltd., Zydus Pharmaceuticals, Inc., Hikma Pharmaceuticals PLC, NATCO Pharma Limited, Fresenius Kabi USA, Accord Healthcare, Apotex Inc., Mylan N.V., Cipla Inc., ZHEJIANG HISUN PHARMACEUTICAL Co., LTD., Chongqing Huapont Pharmaceutical Co., Ltd., YZJ Group, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., and Aurobindo Pharma
High cost of treatment and side effects associated with the medication such as headache, shortness of breath, osteoporosis, skin reaction, high cholesterol levels, depression, high blood pressure, swelling in lymph nodes, muscle pain and liver problems are the factors that will hinder the market growth and will further challenge the anastrozole tablets market
The regions covered in the anastrozole tablets market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
